Trials / Completed
CompletedNCT04450134
Histamine H1/H2 Receptors and Training Adaptations
Role of Histamine H1/H2 Receptors in the Health- and Performance-promoting Adaptations to High-intensity Interval Training
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University Ghent · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Exercise training is beneficial for both health and performance. Histamine has been shown to be involved in the acute exercise response. The current study addresses the role of histamine H1/H2 receptor signaling in the chronic training-induced adaptations. Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lactose | Placebo: Lactose capsules |
| DRUG | Fexofenadine Hydrochloride | H1 receptor antagonist: 540 mg Fexofenadine Hydrochloride |
| DRUG | Famotidine | H2 receptor antagonist: 40 mg Famotidine |
| OTHER | High-intensity interval training (HIIT) | 6 weeks HIIT |
Timeline
- Start date
- 2019-10-02
- Primary completion
- 2019-12-18
- Completion
- 2021-04-14
- First posted
- 2020-06-29
- Last updated
- 2024-06-07
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04450134. Inclusion in this directory is not an endorsement.